1-9 of 9
Peter J Grant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t

Nikolaus Marx, Peter J. Grant
Journal: Diabetes Care
Diabetes Care 2020;43(9):1991–1993
https://doi.org/10.2337/dci20-0027
Published: 11 August 2020
View article titled, Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t
Open the PDF for Prescribing Paradigm Shift? Damned If You Do, Damned If You Don’t in another window
Journal Articles

Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes

Maike Anderssohn, Stela McLachlan, Nicole Lüneburg, Christine Robertson, Edzard Schwedhelm, Rachel M. Williamson, Mark W.J. Strachan, Ramzi Ajjan, Peter J. Grant, Rainer H. Böger, Jackie F. Price
Journal: Diabetes Care
Diabetes Care 2014;37(3):846–854
https://doi.org/10.2337/dc13-0546
Published: 11 February 2014
View article titled, Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes
Open the PDF for Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes in another window
Journal Articles

Elevated Properdin and Enhanced Complement Activation in First-Degree Relatives of South Asian Subjects With Type 2 Diabetes

Riyaz Somani, PHD, Victoria R. Richardson, MSC, Kristina F. Standeven, PHD, Peter J. Grant, MD, Angela M. Carter, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(4):894–899
https://doi.org/10.2337/dc11-1483
Published: 13 March 2012
View article titled, Elevated Properdin and Enhanced Complement Activation in First-Degree Relatives of South Asian Subjects With Type 2 Diabetes
Open the PDF for Elevated Properdin and Enhanced Complement Activation in First-Degree Relatives of South Asian Subjects With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Aspirin and Mortality in Patients With Diabetes Sustaining Acute Coronary Syndrome

Richard M. Cubbon, MBCHB, Christopher P. Gale, PHD, Adil Rajwani, MBCHB, Afroze Abbas, MBCHB, Christine Morrell, RGNSCM, Raj Das, MD, Julian H. Barth, MD, Peter J. Grant, MD, Mark T. Kearney, MD, Alistair S. Hall, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(2):363–365
https://doi.org/10.2337/dc07-1745
Published: 01 February 2008
View article titled, Aspirin and Mortality in Patients With Diabetes Sustaining Acute Coronary Syndrome
Open the PDF for Aspirin and Mortality in Patients With Diabetes Sustaining Acute Coronary Syndrome in another window
Journal Articles

Study of the −429 T/C and −374 T/A Receptor For Advanced Glycation End Products Promoter Polymorphisms in Diabetic and Nondiabetic Subjects With Macrovascular Disease

Barry I. Hudson, PHD, Max H. Stickland, T. Simon Futers, PHD, Peter J. Grant, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2001;24(11):2004
https://doi.org/10.2337/diacare.24.11.2004
Published: 01 November 2001
View article titled, Study of the −429 T/C and −374 T/A Receptor For Advanced Glycation End Products Promoter Polymorphisms in Diabetic and Nondiabetic Subjects With Macrovascular Disease
Open the PDF for Study of the −429 T/C and −374 T/A Receptor For Advanced Glycation End Products Promoter Polymorphisms in Diabetic and Nondiabetic Subjects With Macrovascular Disease in another window
Journal Articles

Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 Diabetes

Dinesh K Nagi, MRCP, PHD, Lynn J McCormack, MSC, Vidya Mohamed-Ali, MSC, John S Yudkin, MD, FRCP, William C Knowler, MD, DRPH, Peter J Grant, MD, FRCP
Journal: Diabetes Care
Diabetes Care 1997;20(8):1304–1309
https://doi.org/10.2337/diacare.20.8.1304
Published: 01 August 1997
View article titled, Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 Diabetes
Open the PDF for Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 Diabetes in another window
Journal Articles

β-fibrinogen gene −455 G/A Polymorphism and Fibrinogen Levels: Risk factors for coronary artery disease in subjects with NIDDM

Angela M Carter, BSC, Michael W Mansfield, MRCP, Max H Stickland, ABMLS, Peter J Grant, FRCP
Journal: Diabetes Care
Diabetes Care 1996;19(11):1265–1268
https://doi.org/10.2337/diacare.19.11.1265
Published: 01 November 1996
View article titled, β-fibrinogen gene −455 G/A Polymorphism and Fibrinogen Levels: Risk factors for coronary artery disease in subjects with NIDDM
Open the PDF for β-fibrinogen gene −455 G/A Polymorphism and Fibrinogen Levels: Risk factors for coronary artery disease in subjects with NIDDM in another window
Journal Articles

The Effects of High- and Medium-Dose Metformin Therapy on Cardiovascular Risk Factors in Patients With Type II Diabetes

Peter J Grant, MD
Journal: Diabetes Care
Diabetes Care 1996;19(1):64–66
https://doi.org/10.2337/diacare.19.1.64
Published: 01 January 1996
View article titled, The Effects of High- and Medium-Dose Metformin Therapy on Cardiovascular Risk Factors in Patients With Type II Diabetes
Open the PDF for The Effects of High- and Medium-Dose Metformin Therapy on Cardiovascular Risk Factors in Patients With Type II Diabetes in another window
Journal Articles

Fibrinolysis and Diabetic Retinopathy in NIDDM

Michael W Mansfield, MRCP(UK), Peter J Grant, MD
Journal: Diabetes Care
Diabetes Care 1995;18(12):1577–1581
https://doi.org/10.2337/diacare.18.12.1577
Published: 01 December 1995
View article titled, Fibrinolysis and Diabetic Retinopathy in NIDDM
Open the PDF for Fibrinolysis and Diabetic Retinopathy in NIDDM in another window